199 related articles for article (PubMed ID: 35603156)
1. Hematological Prognostic Scoring System Can Predict Overall Survival and Can Indicate Response to Immunotherapy in Patients With Osteosarcoma.
Li L; Wang Y; He X; Li Z; Lu M; Gong T; Chang Q; Lin J; Liu C; Luo Y; Min L; Zhou Y; Tu C
Front Immunol; 2022; 13():879560. PubMed ID: 35603156
[TBL] [Abstract][Full Text] [Related]
2. A Nutritional Metabolism Related Prognostic Scoring System for Patients With Newly Diagnosed Osteosarcoma.
Li L; Li Z; He X; Wang Y; Lu M; Gong T; Chang Q; Lin J; Luo Y; Min L; Zhou Y; Tu C
Front Nutr; 2022; 9():883308. PubMed ID: 35571914
[TBL] [Abstract][Full Text] [Related]
3. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment phenotypes and prognostic evaluation tools for osteosarcoma characterized by different prognostic outcomes and immunotherapy responses.
Tu Z; Li W; Chen Z; Jiang D; Zhou S; Lv S; Cui H
J Gene Med; 2024 Jan; 26(1):e3572. PubMed ID: 37525871
[TBL] [Abstract][Full Text] [Related]
5. Signature based on metabolic-related gene pairs can predict overall survival of osteosarcoma patients.
Li LQ; Zhang LH; Yuan YB; Lu XC; Zhang Y; Liu YK; Wen J; Khader MA; Liu T; Li JZ; Zhang Y
Cancer Med; 2021 Jul; 10(13):4493-4509. PubMed ID: 34047495
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.
Chen B; Zeng Y; Liu B; Lu G; Xiang Z; Chen J; Yu Y; Zuo Z; Lin Y; Ma J
Front Endocrinol (Lausanne); 2021; 12():672024. PubMed ID: 34393996
[TBL] [Abstract][Full Text] [Related]
9. Evaluating and Predicting the Probability of Death in Patients with Non-Metastatic Osteosarcoma: A Population-Based Study.
Huang R; Xian S; Shi T; Yan P; Hu P; Yin H; Meng T; Huang Z
Med Sci Monit; 2019 Jun; 25():4675-4690. PubMed ID: 31231119
[TBL] [Abstract][Full Text] [Related]
10. Metastasis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Qin S; Li L; Liu D
Aging (Albany NY); 2023 Jul; 15(14):7219-7236. PubMed ID: 37494671
[TBL] [Abstract][Full Text] [Related]
11. Development and external validation of nomograms predicting distant metastases and overall survival after neoadjuvant chemotherapy and surgery for patients with nonmetastatic osteosarcoma: A multi-institutional study.
Ogura K; Fujiwara T; Yasunaga H; Matsui H; Jeon DG; Cho WH; Hiraga H; Ishii T; Yonemoto T; Kamoda H; Ozaki T; Kozawa E; Nishida Y; Morioka H; Hiruma T; Kakunaga S; Ueda T; Tsuda Y; Kawano H; Kawai A
Cancer; 2015 Nov; 121(21):3844-52. PubMed ID: 26194185
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma.
Zong Y; Cao Y; Zhang D; Guan X; Zhang F; Shen Z; Yin F
Sci Rep; 2023 Jun; 13(1):9118. PubMed ID: 37277499
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
[TBL] [Abstract][Full Text] [Related]
14. Bone Microenvironment and Osteosarcoma Metastasis.
Yang C; Tian Y; Zhao F; Chen Z; Su P; Li Y; Qian A
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977425
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes.
Qi W; Yan Q; Lv M; Song D; Wang X; Tian K
Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109
[No Abstract] [Full Text] [Related]
16. Nomograms for predicting overall survival and cancer-specific survival of chondroblastic osteosarcoma patients.
Gao Z; Zhou S; Song H; Wang Y; He X
J Surg Oncol; 2020 Dec; 122(8):1676-1684. PubMed ID: 32862456
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Lei T; Qian H; Lei P; Hu Y
Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
[TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma.
Yang QK; Lai QY; Wang Y; Wang Y; Yao ZX; Zhang XJ
Neoplasma; 2021 Mar; 68(2):434-446. PubMed ID: 33118831
[TBL] [Abstract][Full Text] [Related]
19. Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysis.
Ilcisin LA; Ma C; Janeway KA; DuBois SG; Shulman DS
Pediatr Blood Cancer; 2021 Mar; 68(3):e28834. PubMed ID: 33258278
[TBL] [Abstract][Full Text] [Related]
20. Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma.
Yao S; Deng M; Du X; Chen Q; Huang R
J Immunol Res; 2022; 2022():2181525. PubMed ID: 36254197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
